Many studies have shown a correlation between the expression of CD133 and that of stemness-related transcriptional factors, supporting the proposed role of CD133 in conferring cancer stemness and self-renewal potential in CSCs [17,18,19,20]. This evidence concerns the gene PROM1 and cancer.